Dried Blood Spot Collection Cards Market Growth Set to Surge Significantly by 2034

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Dried Blood Spot Collection Cards Market - (By Application (Newborn Screening, Infectious Disease Testing, Forensic Testing, Forensic Testing, CRO/Research, Other Applications), By Card Type (Whatman 903, Ahlstrom 226, FTA, Others), By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Dried Blood Spot Collection Cards Market is valued at US$ 377.9 million in 2023, and it is expected to reach US$ 537.8 Billion by 2031, with a CAGR of 4.7% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2654

DBS (Dried blood spot) collection cards are used to collect and store blood samples for various diagnostic and research purposes. These cards are particularly valuable in remote and resource-limited settings due to their ease of use, low cost, and minimal storage requirements. The increasing prevalence of diseases, rising demand for newborn screening, and growing adoption of DBS in clinical trials and therapeutic drug monitoring are key factors driving the market. Technological advancements in DBS card manufacturing and increasing government initiatives to enhance healthcare infrastructure are expected to further boost market growth. However, challenges such as the potential for sample contamination and the requirement for proper handling and storage protocols may hinder market expansion. The utilization of Dried Blood Spot (DBS) is on the rise, particularly in HIV and hepatitis testing, presenting promising growth prospects for the market. Furthermore, the expanding population, coupled with government support for Newborn Screening (NBS), serves as a significant catalyst driving market expansion.

List of Prominent Players in the Dried Blood Spot Collection Cards Market:
• QIAGEN
• PerkinElmer
• Roche
• Shimadzu Corporation
• Ahlstrom-Munksjö
• Pall Corporation
• Eastern Business Forms, Inc
• Archimed Life Science Gmbh
• Centogene N.V.

Market Dynamics:
Drivers-
The demand for newborn screening is on the rise due to increasing awareness and government efforts aimed at early detection of genetic and metabolic disorders in infants, which is boosting the market for DBS collection cards. Additionally, the growing prevalence of infectious diseases like HIV, hepatitis, and COVID-19 is creating a need for efficient and affordable diagnostic tools, further driving market growth. Technological advancements in the design as well as manufacturing of DBS cards, including enhancements in sample quality and storage capabilities, are also expected to increase market adoption.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-08

Challenges:
Key challenges include regulatory and compliance issues due to variability in sample quality and handling, which can impact the reliability of diagnostic results. Additionally, there is limited awareness and adoption among healthcare professionals and patients, especially in developing regions. High initial costs for setup and validation of DBS methods compared to traditional blood sampling techniques also pose barriers. Furthermore, there are concerns about the stability and integrity of samples over long storage periods and under varying environmental conditions. These factors collectively hinder the widespread adoption and growth of DBS collection cards in the market.

Regional Trends:
The developed healthcare systems, kind regulatory framework, and high incidence of infectious and chronic illnesses such as COVID-19, hepatitis, and HIV are the main factors in North America. Furthermore, a significant emphasis on research and development results in ongoing enhancements to the functionality and design of DBS cards, which boosts their uptake. The market for DBS collection cards is expanding in both regions thanks to a mix of factors, including favourable healthcare regulations, technology developments, and a rising desire for early disease detection. Numerous reasons are driving the remarkable rise of the Dried Blood Spot (DBS) collection cards market in both the Asia-Pacific (APAC) and North America regions. Demand is increasing in APAC as a result of growing awareness and government initiatives for the early detection of genetic and metabolic abnormalities in infants.

Recent Developments:
• In July 2023, Roche has obtained FDA approval for cobas® pro serology solution, which was utilized for serological screening to guarantee the safety of the blood and plasma supply in the United States. The approval encompassed the cobas pro serology solution and the initial test in a series, the Elecsys® HIV Duo, which is designed to qualitatively identify and distinguish HIV-1 p24 antigen and antibodies to HIV, including HIV-1 (groups M and O) and HIV-2.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2654

Segmentation of Dried Blood Spot Collection Cards Market-
By Application:
• Newborn Screening
• Infectious Disease Testing
• Therapeutic Drug Monitoring
• Forensic Testing
• CRO/Research
• Other Applications
By Card Type
• Whatman 903
• Ahlstrom 226
• FTA
• Others
By End User:
• Hospitals and Clinics
• Diagnostic Laboratories
• Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us: InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.